ArticleOncoTargets and therapy2022

A Response to Article Anlotinib Hydrochloride and PD-1 Blockade as a Salvage Second-Line Treatment in Patients with Progress of Local Advanced Non-Small Cell Lung Cancer in Half a Year after Standard Treatment [Letter].

Novaria Sari Dewi PanjaitanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.